Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Choosing the right retirement account can be challenging. Learn about various options to find the best retirement account tailored for your needs.
22,770 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
CrowdStrike forms a strategic tie-up with Nebius Group to integrate Falcon security into Nebius AI Cloud, while repor...
Bitcoin sits roughly 43% below its all-time high as macro headwinds and fund outflows weigh on sentiment. This report...
Bitcoin hovers near $74,000 as market eyes Powell and the Fed. An analyst warns of a repeat sell-the-news pattern, ev...
General Mills faces a turning point in 2026. This in-depth look examines earnings drivers, margins, and cash returns,...
Powell confirms he will remain as chair pro tem if Warsh is not confirmed by mid-May, delivering a clear answer amid ...
The Dow fell nearly 800 points after Fed Chair Powell indicated there is no rush to rescue the market, triggering bro...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
New heart health guidelines urge Lp(a) testing for at-risk adults, sending demand for diagnostics higher. This report...
January new-home activity sank 17.6% to 587,000 SAAR, with prices sliding and winter weather cited as a key acceleran...
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
Nebius Group launches a $4 billion convertible-note round to accelerate a 1.2 GW AI data center project, backed by Nv...